Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate: Comment

Authors

  • Bill T. AMEREDES

    1. Asthma, Allergy, and Airway Research Center, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, USA
    Search for more papers by this author

No abstract is available for this article.

Ancillary